Chun T, Pattem J, Gillis R, Dinu V, Yakubov G, Corfield A
Sci Rep. 2023; 13(1):11367.
PMID: 37443326
PMC: 10344913.
DOI: 10.1038/s41598-023-38036-6.
Chun T, Pattem J, Gillis R, Dinu V, Yakubov G, Corfield A
Sci Rep. 2023; 13(1):1969.
PMID: 36737502
PMC: 9895975.
DOI: 10.1038/s41598-023-28740-8.
Lade H, Joo H, Kim J
Antibiotics (Basel). 2022; 11(10).
PMID: 36290036
PMC: 9598170.
DOI: 10.3390/antibiotics11101378.
Riu F, Ruda A, Ibba R, Sestito S, Lupinu I, Piras S
Pharmaceuticals (Basel). 2022; 15(8).
PMID: 36015090
PMC: 9414505.
DOI: 10.3390/ph15080942.
Galzitskaya O, Kurpe S, Panfilov A, Glyakina A, Grishin S, Kochetov A
Int J Mol Sci. 2022; 23(10).
PMID: 35628272
PMC: 9140876.
DOI: 10.3390/ijms23105463.
Bacterial Targets of Antibiotics in Methicillin-Resistant .
Lade H, Kim J
Antibiotics (Basel). 2021; 10(4).
PMID: 33917043
PMC: 8067735.
DOI: 10.3390/antibiotics10040398.
Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.
Batalha P, Forezi L, Lima C, Pauli F, Boechat F, de Souza M
Bioorg Chem. 2020; 106:104488.
PMID: 33261844
PMC: 7676325.
DOI: 10.1016/j.bioorg.2020.104488.
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.
Dhingra S, Rahman N, Peile E, Rahman M, Sartelli M, Hassali M
Front Public Health. 2020; 8:535668.
PMID: 33251170
PMC: 7672122.
DOI: 10.3389/fpubh.2020.535668.
Adaptation to Disinfectants and Hand Sanitisers, and Evaluation of Cross-Tolerance with Antimicrobials.
de Carvalho C, Teixeira R, Fernandes P
Antibiotics (Basel). 2020; 9(9).
PMID: 32867093
PMC: 7559525.
DOI: 10.3390/antibiotics9090544.
Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days.
Ueda T, Takesue Y, Nakajima K, Ichiki K, Ishikawa K, Takai Y
BMC Pharmacol Toxicol. 2020; 21(1):50.
PMID: 32641110
PMC: 7341468.
DOI: 10.1186/s40360-020-00424-3.
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements.
Pandey A, Nikam A, Shreya A, Mutalik S, Gopalan D, Kulkarni S
Life Sci. 2020; 256:117883.
PMID: 32497632
PMC: 7263255.
DOI: 10.1016/j.lfs.2020.117883.
Mycobacterial Response to Organic Solvents and Possible Implications on Cross-Resistance With Antimicrobial Agents.
Pacifico C, Fernandes P, de Carvalho C
Front Microbiol. 2018; 9:961.
PMID: 29867865
PMC: 5962743.
DOI: 10.3389/fmicb.2018.00961.
Teicoplanin - Tigecycline Combination Shows Synergy Against .
Aziz D, Teo J, Dartois V, Dick T
Front Microbiol. 2018; 9:932.
PMID: 29867841
PMC: 5958212.
DOI: 10.3389/fmicb.2018.00932.
Derringer desirability and kinetic plot LC-column comparison approach for MS-compatible lipopeptide analysis.
DHondt M, Verbeke F, Stalmans S, Gevaert B, Wynendaele E, De Spiegeleer B
J Pharm Anal. 2018; 4(3):173-182.
PMID: 29403880
PMC: 5761130.
DOI: 10.1016/j.jpha.2013.09.001.
Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci.
Hughes C, Longo E, Phillips-Jones M, Hussain R
Biochim Biophys Acta Gen Subj. 2017; 1861(8):1951-1959.
PMID: 28511809
PMC: 5482315.
DOI: 10.1016/j.bbagen.2017.05.011.
Phenotypic Modifications in Staphylococcus aureus Cells Exposed to High Concentrations of Vancomycin and Teicoplanin.
Goncalves F, de Carvalho C
Front Microbiol. 2016; 7:13.
PMID: 26834731
PMC: 4724715.
DOI: 10.3389/fmicb.2016.00013.
Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach.
Economou N, Zentner I, Lazo E, Jakoncic J, Stojanoff V, Weeks S
Acta Crystallogr D Biol Crystallogr. 2013; 69(Pt 4):520-33.
PMID: 23519660
PMC: 3606034.
DOI: 10.1107/S0907444912050469.
Teicoplanin-induced leucopenia with immediate resolution after administration of G-CSF.
Patel P, Sandoe J, Baig W
BMJ Case Rep. 2012; 2012.
PMID: 22891005
PMC: 3433501.
DOI: 10.1136/bcr.01.2012.5668.
A risk-benefit assessment of teicoplanin in the treatment of infections.
De Lalla F, Tramarin A
Drug Saf. 1995; 13(5):317-28.
PMID: 8785019
DOI: 10.2165/00002018-199513050-00005.
Effects of the new glycopeptide antibiotic teicoplanin on platelet function and blood coagulation.
Agnelli G, Longetti M, Guerciolini R, Menichetti F, Grasselli S, Boldrini F
Antimicrob Agents Chemother. 1987; 31(10):1609-12.
PMID: 2963587
PMC: 175000.
DOI: 10.1128/AAC.31.10.1609.